Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka

Update for the MRCP

Volume 2

9780443062575
176,35 zł
158,71 zł Zniżka 17,64 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 158,71 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
A book of 150 MCQs, each with five parts, based on the current medical literature with full references to recent papers and full explanatory answers. The questions will thus be linked to research papers and reflect the increasing importance of basic science in clinical medicine. Although based on key papers not all of these will be in the last year and thus the book wont date that quickly. The book also contains useful appendices to assist candidates in their preparation for the exam.
Szczegóły produktu
Churchill Livingstone
37250
9780443062575
9780443062575

Opis

Rok wydania
2000
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
310
Waga (g)
440
  • CONTENTS
    Questions

    Basic science, immunology and genetics
    1. Mechanisms of cell death
    2. T cell activation
    3. T helper (Th2) cells
    4. Chemokines
    5, 6. Chemokines and HIV-1 receptors
    7. IGE in asthma
    8. Allergen immunotherapy
    9. Vaccination for hepatitis B virus (HBV)
    10. Flow cytometry
    11. The human genome project
    12. Neurogenetics
    13. The mitochondrial genome
    14. Prothrombin-gene G20210A mutation
    15. Nutritional requirements
    Pharmacology and drug development
    16. Drug development
    17. The yellow card scheme for reporting suspected adverse reactions
    18. Study designs
    19. Concerning clinical trials
    20. Cytochrome P450 enzymes
    21. Oral bioavailability of drugs augmented by grapefruit juice
    Therapeutics
    22, 23. Prolongation of the QT interval
    24. Inhaled beclomethasone dipropionate
    25. Cyclo-oxygenase (COX)
    26. Sildenafil
    27. The new epilepsy drugs
    28. Drug treatments for depression
    29. Drug treatment of Alzheimers disease
    30. 5 fluorouracil
    31. Paclitaxel
    32. Doxorubicin induced cardiomyopathy
    33. Ecstasy
    34. Cannabis
    35. Carbon monoxide poisoning
    36. Drug induced hypokalaemia
    37. Treating a patient with glucocorticoids
    Neurology
    38. Haematological causes of acute stroke
    39. Status epilepticus
    40. Friedreichs ataxia
    41. diabetic peripheral neuropathy
    42. Parkinsons disease
    43. Neurosurgical treatments of Parkinsons disease
    44. Trinucleotide repeat disorders
    45. Diagnosis and management of migraine
    46. Pathology of migraine
    47. Management of headache
    Respiratory medicine
    47. Brittle asthma
    48. Bronchial asthma
    50. Alpha antitrypsin (AAT)
    51, 52. Pulmonary fibrosis
    53. Nebuliser therapy
    54. Primary pulmonary hypertension
    55. Lung volume reduction surgery
    56. Lung transplantation
    Endocrinology
    57. Causes of hirsutism in women
    58. Polycystic ovary syndrome
    59. Endocrine hypertension
    60. Phaeochromocytoma
    61. Multiple endocrine neoplasia (MEN)
    62, 63. Type 2 diabetes mellitus
    64. Hypothyroidism
    65, 66. Common causes of primary hypothyroidism
    67. Adult growth hormone deficiency (GHD)
    68. Carcinoid tumours
    Cardiology
    69. Cardiac physiology
    70. Unstable angina and non-Q wave myocardial infarction
    71. Ventricular fibrillation (VF)
    72, 73. Chronic heart failure
    74. Ischaemic heart disease
    75. Antiplatelet agents in coronary artery disease
    76. Arrhythmogenic right ventricular dysplasia (ARVD)
    77. Right ventricular infarction
    Gastroenterology
    78. Primary biliary cirrhosis
    79. Acute pancreatitis
    80. Barretts oesophagus
    81. Management of obesity
    82. Hepatitis A infection
    83. Haemochromatosis
    84. Assessment of nutritional status
    85. Nutritional supplementation
    86. Patient presenting with general malaise as a result of short bowel syndrome
    87. Management of gastro-oesophageal reflux disease
    88, 89 Coeliac disease

    Nephrology
    90. The nephrotic syndrome
    91, 92. Solid organ transplantation
    93. Atheromatous renovascular disease
    94. During pregnancy
    95. Kidney stones
    96. Acute renal failure
    97. End-stage renal failure
    98. Management of rhabdomyolysis
    99. IgA nephropathy
    Infectious diseases
    100 Leprosy
    101. Parasite presentation
    102. Pathology mediated by exotoxins
    103. Nematodes that migrate through the lung
    104. Diseases transmitted by specific vectors
    105. Relative contraindications to the use of antimalarial drugs
    106. Clinical diagnostic methods of choice
    107. Infections
    108. Antimicrobials
    HIV
    109. Clinical features of acute HIV-1 infection
    110. Pathogeneisis of acute HIV-1 infection
    111. Effect of HIV infection on the immune system
    112. Immune reconstitution in HIV positive patients treated with highly active antiretroviral therapy
    (HAART)
    113. British HIV association (BHIVA) guidelines for the treatment of HIV-1 infection
    114. Treatment of HIV infected patients with highly active antiretroviral therapy (HAART)
    115. Reservoirs of HIV-1 in patients receiving highly active antiretroviral therapy (HAART)
    116. Adverse effects of antiretroviral therapy
    117. Resistance to antiretroviral drugs
    Oncology
    118, 119. Radiotherapy
    120. Adjuvant chemotherapy
    121. Immunotherapy
    122. Tamoxifen
    123. Screening
    124 Non small cell lung cancer
    125. High grade B cell non Hodgkins lymphoma
    126. Control of cancer pain
    Haematology
    127. Patients with multiple myeloma
    128. Patients with sickle cell disease
    129. Heparin-induced thrombocytopenia (type 2)
    130. High homocysteine levels
    131. Chronic myeloid leukaemia (CML)
    132. Essential thrombocytopenia
    133. Severe haemophilia A
    134. Human T-cell leukaemia (HTLV) viruses
    135. Acute myeloid leukaemia (AML)
    Rheumatology
    136. Anti-neutrophil cytoplasmic antibodies (ANCA)
    137. Scleroderma
    138. HIV infection compared to the normal population
    139. Mixed cryoglobulinaemia
    140. Poor prognostic markers in patients presenting with rheumatoid arthritis
    141. Bone mineral density (BMD)
    Dermatology
    142. Acne vulgaris
    143. Alopecia
    144. Atopic eczema
    145. Pyoderma gangrenosum
    146. Mycosis fungoides
    147. Psoriasis
    148. Effects of ultraviolet radiation (UVR) on the skin
    149. Skin cancer in organ-transplant recipients
    150. Neurocutaneous disorders

    Answers

    VIVA questions

    References

    Abbreviations

    Index
Komentarze (0)
Ostatnio przeglądane

  • Często kupowane razem

    Brak dostępnych produktów